FDA mandates changes to metformin labelling

US Food and Drug Administration (FDA) has changed its advice on prescribing metformin for type 2 patients with impaired kidney function.

In a statement just released, the agency says the drug can be used safely “in some patients whose kidneys do not work normally”.

“We have concluded from the review of studies published in the medical